Korea Investment Corp Vertex Pharmaceuticals Inc Transaction History

Korea Investment Corp

$38.9 Billion
Q2 2024

A detailed history of Korea Investment Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Korea Investment Corp holds 214,800 shares of VRTX stock, worth $102 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

214,800

Previous 238,777 10.04%

Holding current value

$102 Million

Previous $99.8 Million 0.87%

% of portfolio

0.26%

Previous 0.26%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $9.42 Million - $11.6 Million	-23,977 Reduced 10.04%	214,800 $101 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $26.1 Million - $28.6 Million	-64,062 Reduced 21.15%	238,777 $99.8 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $7.72 Million - $9.24 Million	22,498 Added 8.03%	302,839 $123 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $25.2 Million - $27 Million	-74,430 Reduced 20.98%	280,341 $97.5 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $4.78 Million - $5.35 Million	-15,209 Reduced 4.11%	354,771 $125 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $3.32 Million - $3.78 Million	11,709 Added 3.27%	369,980 $117 Million
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $644,960 - $725,580	2,257 Added 0.63%	358,271 $103 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $14.1 Million - $15.7 Million	51,315 Added 16.84%	356,014 $103 Million
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $12.3 Million - $15.4 Million	52,490 Added 20.81%	304,699 $85.9 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $6.31 Million - $7.44 Million	28,512 Added 12.75%	252,209 $65.8 Million
Q4 2021 Feb 09, 2022	BUY	$177.01 - $223.45 $13.8 Million - $17.5 Million	78,111 Added 53.65%	223,697 $49.1 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $14.6 Million - $16.4 Million	-80,615 Reduced 35.64%	145,586 $26.4 Million
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $827,580 - $975,935	4,414 Added 1.99%	226,201 $45.6 Million
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $14.4 Million - $16.8 Million	69,556 Added 45.69%	221,787 $47.7 Million
Q4 2020 Feb 10, 2021	SELL	$207.01 - $276.09 $8.4 Million - $11.2 Million	-40,569 Reduced 21.04%	152,231 $36 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $1.28 Million - $1.52 Million	5,000 Added 2.66%	192,800 $52.5 Million
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $1.42 Million - $1.86 Million	6,300 Added 3.47%	187,800 $54.5 Million
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $2.94 Million - $3.64 Million	14,700 Added 8.81%	181,500 $43.2 Million
Q4 2019 Feb 11, 2020	SELL	$166.71 - $223.91 $1.98 Million - $2.66 Million	-11,900 Reduced 6.66%	166,800 $36.5 Million
Q3 2019 Nov 12, 2019	SELL	$166.23 - $187.09 $1.46 Million - $1.65 Million	-8,800 Reduced 4.69%	178,700 $30.3 Million
Q2 2019 Aug 12, 2019	BUY	$164.61 - $190.37 $5.74 Million - $6.64 Million	34,900 Added 22.87%	187,500 $34.4 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $914,432 - $1.09 Million	5,585 Added 3.8%	152,600 $28.1 Million
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $1.66 Million - $2.1 Million	-10,900 Reduced 6.9%	147,015 $24.4 Million
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $2.41 Million - $2.77 Million	-14,387 Reduced 8.35%	157,915 $30.4 Million
Q2 2018 Aug 13, 2018	BUY	$145.72 - $169.96 $7.04 Million - $8.21 Million	48,300 Added 38.95%	172,302 $0
Q1 2018 May 09, 2018	BUY	$151.6 - $177.13 $2.91 Million - $3.4 Million	19,200 Added 18.32%	124,002 $20.2 Million
Q4 2017 Feb 12, 2018	SELL	$137.28 - $155.55 $1.26 Million - $1.43 Million	-9,200 Reduced 8.07%	104,802 $15.7 Million
Q3 2017 Oct 25, 2017	BUY	$148.13 - $162.24 $16.9 Million - $18.5 Million	114,002	114,002 $17.3 Million

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.

Account

Korea Investment Corp Vertex Pharmaceuticals Inc Transaction History